Pharmacokinetics study of piperacillin-tazobactam and meropenem in obese patients

Trial Profile

Pharmacokinetics study of piperacillin-tazobactam and meropenem in obese patients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Jul 2017

At a glance

  • Drugs Meropenem (Primary) ; Piperacillin/tazobactam (Primary)
  • Indications Obesity
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top